Dopaminergic neurons for Parkinson's therapy

Nature Biotechnology

Volumn 30, Issue 1, 2012, Pages 56-58

  Lindvall, Olle ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINERGIC NEURONS;

PATIENT TREATMENT;

NEURONS;

DOPAMINE; WNT PROTEIN;

CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SELECTION; DISEASE COURSE; DOPAMINERGIC NERVE CELL; DYSKINESIA; ELECTROPHYSIOLOGY; EMBRYONIC STEM CELL; HUMAN; LEWY BODY; MOTOR PERFORMANCE; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; REINNERVATION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; SUBSTANTIA NIGRA;

CELL DIFFERENTIATION; DOPAMINERGIC NEURONS; EMBRYONIC STEM CELLS; HUMANS; PARKINSON DISEASE; SMAD PROTEINS, RECEPTOR-REGULATED; TREATMENT OUTCOME; WNT SIGNALING PATHWAY;

EID: 84855519827     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.2077     Document Type: Review

References (10)

1. Lindvall, O. & Björklund, A. Neurotherapeutics 8, 539-548 (2011).
2. Kriks, S. et al. Nature advance online publication, doi:10.1038/ nature10648 (6 November 2011).
3. Politis, M. et al. Sci. Transl. Med. 2, 38ra46 (2010).
4. Kordower, J.H. et al. Nat. Med. 14, 504-506 (2008).
5. Roy, N.S. et al. Nat. Med. 12, 1259-1268 (2006).
6. Cho, M.S. et al. Proc. Natl. Acad. Sci. USA 105, 3392-3397 (2008).
7. Friling, S. et al. Proc. Natl. Acad. Sci. USA 106, 7613-7618 (2009).
8. Lindvall, O. & Kokaia, Z. J. Clin. Invest. 120, 29-40 (2010).
9. Chambers, S.M. et al. Nat. Biotechnol. 27, 275-280 (2009).
10. Fasano, C.A. et al. Cell Stem Cell 6, 336-347 (2010).